Loading
Dawnrays Pharmaceutical (Holdings) Ltd. Stock: price and insider trades · Hong Kong
3 insiders bought €265k of shares over the last 90 days, the latest by LEUNG HONG MAN, filed 15 Oct 2026.
Cluster: 2 buyers in 30 daysDawnrays Pharmaceutical (Holdings) Ltd.: what insiders have been doing
This page follows insider dealings at Dawnrays Pharmaceutical (Holdings) Ltd. as filed with HKEX, a company from the Health Care sector. The last twelve months, up to 23 October 2026, brought 35 filings signed by 4 insiders.
Open-market activity splits into 33 purchases totalling €389k and 1 sale; 3 insiders sit on the buying side and 1 insider on the selling side. No amount is published for 1 filing, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Biggest ticket of the year: €55k, bought by Leung Hong Man and made public on 15 October 2026 (0.033% of market cap). The buyers include 3 senior executives.
The data flag 33 purchases as part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The most recent open-market purchase was published on 15 October 2026, 9 days ago. Filings reach the HKEX feed a median of 2 days after the trade. That lag is the time during which only the insider knows about the trade.
For context, the typical company on the same exchange (median of 1,315 companies) published 4 filings over the same period, against 35 filings here. Over the whole record (from 2017), the tally stands at 334 purchases and 8 sales.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Insider Decl.
576
Thresholds
n/a
Buy Volume
€8M
334 ops. · all time
Sell Volume
n/a
8 ops. · all time
Who traded when
BuySaleHung Yung Lai70 buys
Li Kei Ling15 buys
Leung Hong Man3 buys
Yu Liwei1 sale
Since the insiders bought
- -1.6%Entry HK$0.96 · Close 23 Oct 2026 HK$0.94
- -1.0%Entry HK$0.95 · Close 23 Oct 2026 HK$0.94
- -3.6%Entry HK$0.98 · Close 23 Oct 2026 HK$0.94
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 664 of 26,248 companies
82.9
score / 100
Value92
Quality73
FCF yld17%
Earn yld15%
EV/EBITDA4.0x
ROE6.9%
Gross mgn50%
Net mgn17%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$0.94
Analyst consensus
Income statement
RevenueHK$1.2B
Gross profitHK$612.2M50% margin
EBITDAHK$370.3M30% margin
Net incomeHK$214M20.3% margin
Valuation
PER (trailing)5.5x
P/Book0.4x
Beta0.26
Balance sheet & cash
Market capHK$1.4B
Total debtHK$77.5M
Free Cash FlowHK$236M
Debt / Equity0%
Profitability & ownership
ROE6.9%
ROA3.7%
% insiders67.6%
% institutions3.2%
Last declaration on 15 October 2026
Declarations576 total
412,000 shares@ HK$0.95890.027% mcap30.4% of flowShareXHKGHKEX:DA20261014E00607
Canonical exit: 11 Jan 2027 (T+90)
432,000 shares@ HK$0.97950.029% mcap32.5% of flowShareXHKGHKEX:DA20261014E00643
Canonical exit: 12 Jan 2027 (T+90)
508,000 shares@ HK$0.95410.033% mcap37.1% of flowShareXHKGHKEX:DA20261014E00599
Canonical exit: 10 Jan 2027 (T+90)
60,000 shares@ HK$0.960.0040% mcap4.1% of flowShareXHKGHKEX:DA20261009E00694
Canonical exit: 7 Jan 2027 (T+90)
60,000 shares@ HK$0.9650.0040% mcap4.1% of flowShareXHKGHKEX:DA20261009E00693
Canonical exit: 5 Jan 2027 (T+90)
60,000 shares@ HK$0.9650.0040% mcap4.1% of flowShareXHKGHKEX:DA20261009E00684
Canonical exit: 5 Jan 2027 (T+90)
60,000 shares@ HK$0.960.0040% mcap4.1% of flowShareXHKGHKEX:DA20261009E00691
Canonical exit: 7 Jan 2027 (T+90)
84,000 shares@ HK$0.96670.0056% mcap6.3% of flowShareXHKGHKEX:DA20261007E00013
Canonical exit: 3 Jan 2027 (T+90)
84,000 shares@ HK$0.96670.0056% mcap6.3% of flowShareXHKGHKEX:DA20261007E00012
Canonical exit: 3 Jan 2027 (T+90)
172,000 shares@ HK$0.9730.011% mcap13.7% of flowShareXHKGHKEX:DA20261002E00168
Canonical exit: 29 Dec 2026 (T+90)
172,000 shares@ HK$0.9730.011% mcap13.7% of flowShareXHKGHKEX:DA20261002E00163
Canonical exit: 29 Dec 2026 (T+90)
96,000 shares@ HK$0.9760.0064% mcap8.9% of flowShareXHKGHKEX:DA20260930E00015
Canonical exit: 28 Dec 2026 (T+90)
96,000 shares@ HK$0.9750.0063% mcap8.8% of flowShareXHKGHKEX:DA20260930E00013
Canonical exit: 27 Dec 2026 (T+90)
96,000 shares@ HK$0.9760.0064% mcap8.9% of flowShareXHKGHKEX:DA20260930E00012
Canonical exit: 28 Dec 2026 (T+90)
96,000 shares@ HK$0.9750.0063% mcap8.8% of flowShareXHKGHKEX:DA20260930E00011
Canonical exit: 27 Dec 2026 (T+90)
76,000 shares@ HK$0.9850.0051% mcap8.5% of flowShareXHKGHKEX:DA20260924E00322
Canonical exit: 22 Dec 2026 (T+90)
92,000 shares@ HK$0.9750.0061% mcap10.2% of flowShareXHKGHKEX:DA20260924E00310
Canonical exit: 21 Dec 2026 (T+90)
76,000 shares@ HK$0.9850.0051% mcap5.9% of flowShareXHKGHKEX:DA20260924E00334
Canonical exit: 22 Dec 2026 (T+90)
92,000 shares@ HK$0.9750.0061% mcap7.0% of flowShareXHKGHKEX:DA20260924E00328
Canonical exit: 21 Dec 2026 (T+90)
64,000 shares@ HK$0.97880.0042% mcap7.1% of flowShareXHKGHKEX:DA20260922E00293
Canonical exit: 20 Dec 2026 (T+90)
64,000 shares@ HK$0.97880.0042% mcap4.9% of flowShareXHKGHKEX:DA20260922E00308
Canonical exit: 20 Dec 2026 (T+90)
104,000 shares@ HK$0.9950.0069% mcap11.6% of flowShareXHKGHKEX:DA20260911E00703
Canonical exit: 9 Dec 2026 (T+90)
104,000 shares@ HK$0.9950.0071% mcap0.3% of flowShareXHKGHKEX:DA20260911E00701
Canonical exit: 9 Dec 2026 (T+90)
104,000 shares@ HK$1.000.0069% mcap11.7% of flowShareXHKGHKEX:DA20260905E00056
Canonical exit: 2 Dec 2026 (T+90)
60,000 shares@ HK$0.990.0040% mcap6.7% of flowShareXHKGHKEX:DA20260905E00055
Canonical exit: 3 Dec 2026 (T+90)
25 of 576 declarations
About Dawnrays Pharmaceutical (Holdings) Ltd.
Dawnrays Pharmaceutical (Holdings) Ltd. is a company focused on the development and manufacturing of pharmaceutical products. It is listed on the Hong Kong Stock Exchange (XHKG).
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
